Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Botanical oils enriched in n-6 and n-3 FADS2 products are equally effective in preventing atherosclerosis and fatty liver.

Shewale SV, Boudyguina E, Zhu X, Shen L, Hutchins PM, Barkley RM, Murphy RC, Parks JS.

J Lipid Res. 2015 Jun;56(6):1191-205. doi: 10.1194/jlr.M059170. Epub 2015 Apr 28.

2.

Alpha linolenic acid in maternal diet halts the lipid disarray due to saturated fatty acids in the liver of mice offspring at weaning.

Shomonov-Wagner L, Raz A, Leikin-Frenkel A.

Lipids Health Dis. 2015 Feb 26;14:14. doi: 10.1186/s12944-015-0012-7.

3.

Inflammation and its resolution as determinants of acute coronary syndromes.

Libby P, Tabas I, Fredman G, Fisher EA.

Circ Res. 2014 Jun 6;114(12):1867-79. doi: 10.1161/CIRCRESAHA.114.302699. Review.

4.

SCD1 activity in muscle increases triglyceride PUFA content, exercise capacity, and PPARĪ“ expression in mice.

Rogowski MP, Flowers MT, Stamatikos AD, Ntambi JM, Paton CM.

J Lipid Res. 2013 Oct;54(10):2636-46. doi: 10.1194/jlr.M035865. Epub 2013 Aug 5.

5.

Walnut oil increases cholesterol efflux through inhibition of stearoyl CoA desaturase 1 in THP-1 macrophage-derived foam cells.

Zhang J, Grieger JA, Kris-Etherton PM, Thompson JT, Gillies PJ, Fleming JA, Vanden Heuvel JP.

Nutr Metab (Lond). 2011 Aug 26;8:61. doi: 10.1186/1743-7075-8-61.

6.

Fatty acid regulation of hepatic lipid metabolism.

Jump DB.

Curr Opin Clin Nutr Metab Care. 2011 Mar;14(2):115-20. doi: 10.1097/MCO.0b013e328342991c. Review.

7.

Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol.

Zhang J, Cai S, Peterson BR, Kris-Etherton PM, Heuvel JP.

Assay Drug Dev Technol. 2011 Apr;9(2):136-46. doi: 10.1089/adt.2010.0288. Epub 2010 Nov 4.

8.

TLR4 and Insulin Resistance.

Kim JJ, Sears DD.

Gastroenterol Res Pract. 2010;2010. pii: 212563. doi: 10.1155/2010/212563. Epub 2010 Aug 10.

9.

ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport.

Yin K, Liao DF, Tang CK.

Mol Med. 2010 Sep-Oct;16(9-10):438-49. doi: 10.2119/molmed.2010.00004. Epub 2010 May 12.

10.

The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).

Liu Q, Bengmark S, Qu S.

Lipids Health Dis. 2010 Apr 28;9:42. doi: 10.1186/1476-511X-9-42. Review.

11.

Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.

Brown JM, Rudel LL.

Curr Opin Lipidol. 2010 Jun;21(3):192-7. doi: 10.1097/MOL.0b013e32833854ac. Review.

Supplemental Content

Support Center